{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:08:07Z","timestamp":1779332887988,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.07.007","type":"journal-article","created":{"date-parts":[[2008,8,23]],"date-time":"2008-08-23T06:38:58Z","timestamp":1219473538000},"page":"245-249","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Autoimmune channelopathies: John Newsom-Davis's work and legacy"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Angela","family":"Vincent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.07.007_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib3","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1212\/01.WNL.0000036912.25881.7B","article-title":"Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera","volume":"59","author":"Bernasconi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/brain\/awh415","article-title":"Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement","volume":"128","author":"Bien","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ana.10557","article-title":"Maternal neuronal antibodies associated with autism and a language disorder","volume":"53","author":"Dalton","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib9","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib10","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awl095","article-title":"MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis","volume":"129","author":"Farrugia","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib12","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/brain\/awf178","article-title":"Phenotypic variants of autoimmune peripheral nerve hyperexcitability","volume":"125","author":"Hart","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410410215","article-title":"Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia","volume":"41","author":"Hart","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib15","unstructured":"Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O'Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C.-M., Vincent, A., in press. Progressive encephalomyelitis, rigidity and myoclonus: a novel glycine receptor antibody. Neurology."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib16","unstructured":"Irani, S.R., Buckley, C., Vincent, A., Cockerell, C., Rudge, P., Johnson,-M.R., Smith, S., in press. Immunotherapy \u2013 responsive seizure \u2013 like episodes with potassium channel antibodies. Neurology."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1172\/JCI5943","article-title":"Plasma from human mothers of fetuses with severe arthrogryposis multiplex congenita causes deformities in mice","volume":"103","author":"Jacobson","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1971.tb30750.x","article-title":"Quantal components of end-plate potentials in the myasthenic syndrome","volume":"183","author":"Lambert","year":"1971","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(81)90474-8","article-title":"Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome","volume":"2","author":"Lang","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","article-title":"Thymus changes in anti-MuSK-positive and -negative myasthenia gravis","volume":"64","author":"Lauriola","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","article-title":"Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG","volume":"57","author":"Leite","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib26","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","article-title":"Antibodies to voltage-gated potassium and calcium channels in epilepsy","volume":"71","author":"Majoie","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib29","first-page":"543","article-title":"Evidence for glutamate receptor autoimmunity in the pathogenesis of Rasmussen encephalitis","volume":"79","author":"McNamara","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity","volume":"1","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/jnnp.58.1.85","article-title":"An improved diagnostic assay for Lambert-Eaton myasthenic syndrome","volume":"58","author":"Motomura","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib32","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1212\/WNL.28.3.266","article-title":"Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange","volume":"28","author":"Newsom-Davis","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2007.10.017","article-title":"John M Newsom-Davis","volume":"194","author":"Raine","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib34","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119048","article-title":"Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function","volume":"98","author":"Riemersma","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/317737a0","article-title":"Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line","volume":"317","author":"Roberts","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib36","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib38","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jneuroim.2007.11.004","article-title":"Antibodies against fetal brain in sera of mothers with autistic children","volume":"194","author":"Singer","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0140-6736(91)90073-X","article-title":"Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)","volume":"338","author":"Sinha","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib40","unstructured":"Spinazzi, M., Argentiero, V., Zuliani, L., Palmieri, A., Tavolato, B., Vincent, A., in press. Immunotherapy-reversed compulsive, monoaminergic, circadian rhythm disorder in Morvan Syndrome Neurology."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib41","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib43","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2006.09.024","article-title":"Autoimmune channelopathies and related neurological disorders","volume":"52","author":"Vincent","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally-extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2008.07.007_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.WNL.0000132651.66689.0F","article-title":"Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis","volume":"63","author":"Watson","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib48","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1212\/WNL.57.8.1511","article-title":"GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis","volume":"57","author":"Wiendl","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.07.007_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2007.10.012","article-title":"John Newsom-Davis 1932\u20132007","volume":"194","author":"Willcox","year":"2008","journal-title":"J. Neuroimmunol."}],"updated-by":[{"DOI":"10.1016\/j.jneuroim.2009.02.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,5,29]],"date-time":"2009-05-29T00:00:00Z","timestamp":1243555200000}}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T03:28:43Z","timestamp":1545794923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":49,"alternative-id":["S0165572808002944"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.07.007","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jneuroim.2009.02.014","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}